145 related articles for article (PubMed ID: 8218755)
1. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
Geldof H; Hazelhoff B; Otten MH
Aliment Pharmacol Ther; 1993 Aug; 7(4):409-15. PubMed ID: 8218755
[TBL] [Abstract][Full Text] [Related]
2. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
McKenna CJ; Mills JG; Goodwin C; Wood JR
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two dosing regimens of cisapride in the treatment of reflux oesophagitis.
Schütze K; Bigard MA; Van Waes L; Hinojosa J; Bedogni G; Hentschel E
Aliment Pharmacol Ther; 1997 Jun; 11(3):497-503. PubMed ID: 9218072
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.
Johnson NJ; Boyd EJ; Mills JG; Wood JR
Aliment Pharmacol Ther; 1989 Jun; 3(3):259-66. PubMed ID: 2520621
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
6. Cisapride versus ranitidine in the treatment of reflux esophagitis.
Janisch HD; Hüttemann W; Bouzo MH
Hepatogastroenterology; 1988 Jun; 35(3):125-7. PubMed ID: 3042576
[TBL] [Abstract][Full Text] [Related]
7. Healing and prevention of relapse of reflux oesophagitis by cisapride.
Toussaint J; Gossuin A; Deruyttere M; Hublé F; Devis G
Gut; 1991 Nov; 32(11):1280-5. PubMed ID: 1752455
[TBL] [Abstract][Full Text] [Related]
8. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial.
Arvanitakis C; Nikopoułos A; Theoharidis A; Giannoulis E; Vagios I; Anthopoulou H; Michailidis D; Tourkantonis A
Aliment Pharmacol Ther; 1993 Dec; 7(6):635-41. PubMed ID: 8161670
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
[TBL] [Abstract][Full Text] [Related]
10. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
Richter JE; Long JF
Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
[TBL] [Abstract][Full Text] [Related]
11. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
Carvalhinhos A; Fidalgo P; Freire A; Matos L
Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
[TBL] [Abstract][Full Text] [Related]
12. Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
Jansen JB; Van Oene JC
Aliment Pharmacol Ther; 1999 Dec; 13(12):1611-20. PubMed ID: 10594396
[TBL] [Abstract][Full Text] [Related]
13. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR
Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973
[TBL] [Abstract][Full Text] [Related]
14. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
Archimandritis A; Tzivras M; Fertakis A; Emmanuel A; Laoudi F; Kalantzis N; Anthopoulou H; Michailidis D
Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
[TBL] [Abstract][Full Text] [Related]
15. A comparison of five maintenance therapies for reflux esophagitis.
Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
Lehtola J; Niemelä S; Martikainen J; Krekelä I
Scand J Gastroenterol; 1986 Mar; 21(2):175-80. PubMed ID: 3520796
[TBL] [Abstract][Full Text] [Related]
17. [Cisapride versus ranitidine in reflux esophagitis].
Janisch HD
Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
[No Abstract] [Full Text] [Related]
18. Efficacy of cisapride on symptoms and healing of gastro-oesophageal reflux disease: a review.
Richter JE
Scand J Gastroenterol Suppl; 1989; 165():19-27; discussion 27-8. PubMed ID: 2690321
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies.
Kimmig JM
Aliment Pharmacol Ther; 1995 Jun; 9(3):281-6. PubMed ID: 7654890
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
